Source Search Page

sleepreviewmag.com

Why the First Half of Your Sleep is Crucial for Brain Reset

sleepreviewmag.com > pharmaceuticals

Zevra to Present Full Data from KP1077 Phase 2 Trial in IH at SLEEP 2024

...’s president and CEO Neil McFarlane.... ...A shareholder letter from CEO Neil McFarlane underscores this milestone... ...The drug was approved by the US Food and Drug Administration in 2021... ...teams with experience in rare diseases and the addition of Adrian Quartel...

sleepreviewmag.com

Philips Agrees to Pay $1 Billion to Patients Who Say They Were Injured by Breathing Machines

...Sallah, Pittsburgh Post-Gazette; and Julian Andreone, Medill Investigative... ...Lab Philips Respironics received thousands of complaints about a... ...An investigation by ProPublica and the Pittsburgh Post-Gazette last... ...Department of Justice is ongoing, and the Government Accountability...

sleepreviewmag.com > practice-management > human-resources

LivaNova Adds Chief Innovation Officer

...and the University of California-Santa Barbara.... ...technology company, has appointed Ahmet Tezel as chief innovation... ..., chief executive officer of LivaNova, in a release.... ...in chemical engineering from the University of California-Santa Barbara...

sleepreviewmag.com

Owlet's Dream Sock Receives EU Medical Device Certification

...from the US Food and Drug Administration for Dream Sock, with new... ...This EU CE-Mark certification signifies that Owlet’s Dream Sock has... ...,” says Kurt Workman, Owlet chief executive officer and co-founder... ...launch throughout Germany, France, and the United Kingdom this spring...

sleepreviewmag.com

Fullpower-AI Secures New Patents to Enhance Sleep with Artificial Intelligence

...Trademark Office, enhancing its portfolio in sleep and wellness innovation... ...Fullpower-AI has secured five new patents from the US Patent and... ...and Trademark Office for technologies designed to enhance sleep... ...patent introduces an innovative system for collecting sleep data...

sleepreviewmag.com > pharmaceuticals

Alkermes Reports First Profitable Quarter, Advances Narcolepsy Drug Studies

...Richard Pops.... ...CEO Richard Pops emphasized the potential of orexin biology in addressing... ...Lurker as a new independent director to the board. 7300 W 110th St... ...Alkermes is exploring the potential of orexin 2 biology to address...

sleepreviewmag.com > mental-health

Sleep and Stress Major Players in US Mental Health Concerns, Poll Finds

...The 2024 results of the American Psychiatric Association’s annual... ...May 3, 2024 | Mental Health | 0 | Summary: The 2024 American Psychiatric... ...Association CEO and medical director Saul Levin, MD, MPA, in a release... ...Association president Petros Levounis, MD, MA, in a release....

sleepreviewmag.com

Major Retailers Stop Sales of Weighted Baby Products Amid Safety Concerns

...concerns highlighted by the Consumer Product Safety Commission.... ...Additionally, US Senator Richard Blumenthal has urged the FTC to... ...American Academy of Pediatrics, and the Centers for Disease Control... ...Safety Commission, the National Institutes of Health, the...

sleepreviewmag.com

ResMed, Panthera Settle Patent Infringement Claims

...,” says Gabriel Robichaud, CEO of Panthera Dental, in a release.... ...ResMed spokesperson Brad Lotterman says in an emailed statement,... ...In 2018, Narval CC was discontinued in the US market. 7300 W 110th... ...innovation and more than 9,500 pending or issued patents and designs, ResMed...